Oxford BioMedica
Discover Realise

Key financial information

  • LSE ticker

    OXB

    Listed on London Stock Exchange in 2001, ticker symbol is LSE:OXB

  • Shares in issue

    3,088,268,565

    3,088,268,565 shares in issue

  • Gross income (1)

    £30.8m

    Gross income of £30.8 million in 2016 (2015: £18.8 million)

  • R&D and bioprocessing costs

    £24.3m

    R&D and bioprocessing costs of £24.3 million in 2016 (2015: £20.2 million)

  • Operating loss

    £11.3m

    Operating loss of £11.3 million in 2016 (2015: £14.1 million)

  • Cash burn

    £11.5m

    Cash burn of £11.5 million in 2016 (2015: cash burn £29.8 million)

  • Cash position

    £15.3m

    Net cash of £15.3 million as at 31 December 2016 (£9.4 million as at 31 December 2015)

Footnote:

1. Gross income is the aggregate of revenue and other operating income